Merck MDL Update: Fosamax® "Failure To Warn" In Femur Cases Before Third Circuit Today

Just a minor appellate update squib here -- this flawless holiday morning, over hot coffee & cream, fresh-squeezed OJ, and a banana -- whole cherry yogurt coming up, next -- smile.

Recall that the trial courts have dismissed all the Fosamax^® femur MDL "failure to warn" claims. That July 2014 ruling reduced the number of femur MDL claimants from over 1,000, to under 20. The MDL steering committee has appealed the able Judge Pisano's ruling to the Third Circuit. A full two years later now, that appeal will be heard today, it seems.

Here is the Reuters item noting it.

We will report if anything newsworthy transpires. Onward -- on a mountain bike -- on a glorious morning, eyes a-glow. . . .